References
1. Zaenglein AL. Acne vulgaris. N Engl J Med 2018;379(14):1343-1352.
2. Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: A large, retrospective review. Dermatol Ther 2017;30(4):e12483.
3. Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD. Isotretinoin use and the risk of Inflammatory Bowel Disease: A case control study. Am J Gastroenterol 2010;105(9):1986.
4. Baykal Selçuk L, Aksu Arıca D, Baykal Şahin H, Yaylı S, Bahadır S. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin. Cutan Ocul Toxicol 2017;36(2):176-179.
5. Ataseven A, Kurtipek GS, Ozturk P. Neutrophil lymphocyte ratio in patients receiving isotretinoin for acne vulgaris. Med-Science 2014;3:1026-1031.
6. Haybar H, Pezeshki SMS, Saki N. Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis? Exp Mol Pathol 2019:104267.
7. Tezcan D, Turan Ç, Yılmaz S, et al. What do simple hematological parameters tell us in patients with systemic sclerosis? Acta Dermatovenerol Alp Pannonica Adriat 2020;29(3):101-107.
8. Uslu AU, Sekin Y, Tarhan G, Canakcı N, Gunduz M, Karagulle M. Evaluation of monocyte to high-density lipoprotein cholesterol ratio in the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost 2018;24(5):828-833.
9. Saklamaz A, Uyar B, Yalcin M, Cengiz H. Isotretinoin increased carotid intima-media thickness in acne patients. Hippokratia 2016;20(1):14.
10. Önder S, Ozturk M. Can monocyte/HDL show inflammatory activity of isotretinoin treatment in acne patients? Cutan Ocul Toxicol 2020;39(2):111-114.
11. Solak B, Erdem T, Solak Y. Isotretinoin use for acne vulgaris is associated with increased serum uric acid levels. J Dermatolog Treat 2017;28(1):82-85.
12. Bando H. Recent Topics of Hyperuricemia for Metabolic Syndrome, Cardiovascular, and Chronic Renal Diseases. J Diab Obes Metab 2020;3(1):e104.
13. Chen JW, Li C, Liu ZH, et al. The role of monocyte to high-density lipoprotein cholesterol ratio in prediction of carotid intima-media thickness in patients with type 2 diabetes. Front Endocrinol (Lausanne) 2019;10:191.
14. Chen M-Q, Shi W-R, Shi C-N, Zhou Y-P, Sun Y-X. Impact of monocyte to high-density lipoprotein ratio on prevalent hyperuricemia: findings from a rural Chinese population. Lipids Health Dis 2020;19(1):1-9.
15. Chiang K-M, Tsay Y-C, Vincent Ng T-C, et al. Is hyperuricemia, an early-onset metabolic disorder, causally associated with cardiovascular disease events in han Chinese? J Clin Med 2019;8(8):1202.
16. Kang D-H, Park S-K, Lee I-K, Johnson RJ. Uric acid–induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J. Am. Soc. Nephrol. 2005;16(12):3553-3562.
17. Baldwin W, McRae S, Marek G, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011;60(4):1258-1269.
18. Ali N, Rahman S, Islam S, et al. The relationship between serum uric acid and lipid profile in Bangladeshi adults. BMC Cardiovasc Disord 2019;19(1):42.
19. Peng T-C, Wang C-C, Kao T-W, et al. Relationship between hyperuricemia and lipid profiles in US adults. Biomed Res Int 2015;2015.
20. Georgala S, Papassotiriou I, Georgala C, Demetriou E, Schulpis KH. Isotretinoin therapy induces DNA oxidative damage. Clin Chem Lab Med 2005;43(11):1178-1182.
21. Ozkol HU, Ozkol H, Karadag AS, Bilgili SG, Tuluce Y, Calka O. Oral isotretinoin therapy of acne patients decreases serum paraoxonase-1 activity through increasing oxidative stress. Drug Chem Toxicol 2015;38(1):63-66.
22. Tamer F, Yüksel ME, Avcı E. Is mean platelet volume an inflammatory marker in acne patients treated with isotretinoin? Acta Dermatovenerol Alp Pannonica Adriat 2019;28(2):65-69.
23. Duman N, Uzunali E, Manav V. A comparative study on hematological inflammation markers in Acne Vulgaris. IBRR 2015:1-5.
24. Karadag A, Ertugrul D, Bilgili S, Takci Z, Akin K, Calka O. Immunoregulatory effects of isotretinoin in patients with acne. Br J Dermatol 2012;167(2):433-435.
25. Satilmis S. Role of the monocyte-to-high-density lipoprotein ratio in predicting atrial high-rate episodes detected by cardiac implantable electronic devices. North Clin Istanb 2018;5(2):96.
26. Turkmen D, Altunisik N, Sener S. Investigation of monocyte HDL ratio as an indicator of inflammation and complete blood count parameters in patients with acne vulgaris. Int J Clin Pract 2020:e13639.
27. Thacker SG, Zarzour A, Chen Y, et al. High‐density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology 2016;149(3):306-319.
28. Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 2008;18(6):228-232.
29. Karapınar T, Polat M, Buğdaycı G. Evaluation of subclinical atherosclerosis in Turkish patients with acne vulgaris receiving systemic isotretinoin. Dermatol Ther 2020;33(3):e13307.